Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Cash from Operations: 2020-2024

Historic Cash from Operations for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to -$9.1 million.

  • Journey Medical's Cash from Operations fell 105.96% to -$2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.9 million, marking a year-over-year increase of 85.89%. This contributed to the annual value of -$9.1 million for FY2024, which is 274.18% down from last year.
  • As of FY2024, Journey Medical's Cash from Operations stood at -$9.1 million, which was down 274.18% from $5.2 million recorded in FY2023.
  • Over the past 5 years, Journey Medical's Cash from Operations peaked at $5.2 million during FY2023, and registered a low of -$13.5 million during FY2022.
  • For the 3-year period, Journey Medical's Cash from Operations averaged around -$5.8 million, with its median value being -$9.1 million (2024).
  • Per our database at Business Quant, Journey Medical's Cash from Operations tumbled by 520.54% in 2022 and then surged by 138.72% in 2023.
  • Journey Medical's Cash from Operations (Yearly) stood at $5.1 million in 2020, then plummeted by 142.50% to -$2.2 million in 2021, then plummeted by 520.54% to -$13.5 million in 2022, then spiked by 138.72% to $5.2 million in 2023, then slumped by 274.18% to -$9.1 million in 2024.